A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

To be considered for this study, you need to be at least 50 years old. You must have a diagnosis of Geographic Atrophy (GA) due to Age-related Macular Degeneration (AMD) in at least one eye, which we call the 'study eye'. The area of GA in your study eye needs to be within certain size limits, and your vision in that eye must also be at a specific level.

There are also some reasons why you might not be able to join. For example, if you have another eye condition like "wet" AMD in either eye, or if you've had certain eye surgeries or cell/gene therapies in either eye recently. Also, if your vision loss is due to something other than AMD, or if you have other eye problems that would make it hard for doctors to examine your eye properly, you likely wouldn't be able to take part.

Your study doctor will go through all the specific requirements with you to see if this study is a good fit. It's important to remember these rules are in place to ensure the study is safe and that the results are clear.

If you decide to participate in this study, you would visit the clinic regularly for check-ups and treatments. These visits will include various eye tests, such as vision checks and special scans of your eye, to monitor your condition and how the treatment is affecting it. You will receive either the study medication (FWY003) or a placebo, which will be given in a way determined by the study plan. You won't know which one you are getting. Throughout the study, the research team will keep a close eye on your health and any changes in your vision. The total length of your participation, including all follow-up appointments, will be clearly explained to you by the study team before you make a decision.